Request a Demo
On November 25, 2022, the Center for Drug Reevaluation and the National Center for Adverse Drug Reaction (ADR) Monitoring of China published the draft of Cosmetic Adverse Reaction Collection and Reporting Guidelines for Cosmetic Registrants and Notifiers (Trial) for public feedback. On April 19, 2024, the finalized version of the Guidelines was released.
The Guidelines provides instructions for registrants and notifiers on the collection and reporting of cosmetic adverse reactions, including stages from collection, recording, transmission, to report confirmation, analysis and evaluation, submission, quality control, and record management.
